Krefetz D - Search Results

Year	Number of Results
2001	1
2002	1
2003	1
2008	1
2009	1
2013	1
2015	1
2016	1
2017	1
2021	1
2024	0

1

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O'Neil J, Evans RM, Harrigan P, Plassman BL, Burke JR, Wu J, Lutz MW, Haneline S, Schwarz AJ, Schneider LS, Yaffe K, Saunders AM, Ratti E; TOMMORROW study investigators. Burns DK, et al. Lancet Neurol. 2021 Jul;20(7):537-547. doi: 10.1016/S1474-4422(21)00043-0. Lancet Neurol. 2021. PMID: 34146512 Clinical Trial.

2

Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent.

Preskorn S, Macaluso M, Mehra DO, Zammit G, Moskal JR, Burch RM; GLYX-13 Clinical Study Group. Preskorn S, et al. J Psychiatr Pract. 2015 Mar;21(2):140-9. doi: 10.1097/01.pra.0000462606.17725.93. J Psychiatr Pract. 2015. PMID: 25782764 Clinical Trial.

3

Long-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/ hyperactivity disorder.

Weisler R, Young J, Mattingly G, Gao J, Squires L, Adler L; 304 Study Group. Weisler R, et al. CNS Spectr. 2009 Oct;14(10):573-85. doi: 10.1017/s1092852900024056. CNS Spectr. 2009. PMID: 20095369 Clinical Trial.

4

Lack of age differences in the Beck Depression Inventory-II scores of clinically depressed adolescent outpatients.

Krefetz DG, Steer RA, Kumar G. Krefetz DG, et al. Psychol Rep. 2003 Apr;92(2):489-97. doi: 10.2466/pr0.2003.92.2.489. Psychol Rep. 2003. PMID: 12785631

5

Convergent validity of the Beck depression inventory-II with the reynolds adolescent depression scale in psychiatric inpatients.

Krefetz DG, Steer RA, Gulab NA, Beck AT. Krefetz DG, et al. J Pers Assess. 2002 Jun;78(3):451-60. doi: 10.1207/S15327752JPA7803_05. J Pers Assess. 2002. PMID: 12146814

6

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

Adler LA, Goodman DW, Kollins SH, Weisler RH, Krishnan S, Zhang Y, Biederman J; 303 Study Group. Adler LA, et al. J Clin Psychiatry. 2008 Sep;69(9):1364-73. doi: 10.4088/jcp.v69n0903. Epub 2008 Sep 9. J Clin Psychiatry. 2008. PMID: 19012818 Clinical Trial.

7

Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose Selection.

Krug AW, Vaddady P, Railkar RA, Musser BJ, Cote J, Ederveen A, Krefetz DG, DeNoia E, Free AL, Morrow L, Chakravarthy MV, Kauh E, Tatosian DA, Kothare PA. Krug AW, et al. Among authors: krefetz dg. Clin Transl Sci. 2017 Sep;10(5):404-411. doi: 10.1111/cts.12479. Epub 2017 Jul 20. Clin Transl Sci. 2017. PMID: 28727908 Free PMC article. Clinical Trial.

8

Clinical outcomes from an open-label study of edivoxetine use in pediatric patients with attention-deficit/hyperactivity disorder.

Jin L, Xu W, Krefetz D, Gruener D, Kielbasa W, Tauscher-Wisniewski S, Allen AJ. Jin L, et al. Among authors: krefetz d. J Child Adolesc Psychopharmacol. 2013 Apr;23(3):200-7. doi: 10.1089/cap.2012.0016. J Child Adolesc Psychopharmacol. 2013. PMID: 23607409 Clinical Trial.

9

Screening for major depressive disorders in adolescent psychiatric inpatients with the mood modules from the Primary Care Evaluation of Mental Disorders and the Patient Health Questionnaire.

Kumar G, Kim AH, Krefetz D, Steer RA. Kumar G, et al. Among authors: krefetz d. Psychol Rep. 2001 Oct;89(2):274-8. doi: 10.2466/pr0.2001.89.2.274. Psychol Rep. 2001. PMID: 11783547

10

GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study.

Rodriguez-Torres M, Glass S, Hill J, Freilich B, Hassman D, Di Bisceglie AM, Taylor JG, Kirby BJ, Dvory-Sobol H, Yang JC, An D, Stamm LM, Brainard DM, Kim S, Krefetz D, Smith W, Marbury T, Lawitz E. Rodriguez-Torres M, et al. Among authors: krefetz d. J Viral Hepat. 2016 Aug;23(8):614-22. doi: 10.1111/jvh.12527. Epub 2016 Mar 9. J Viral Hepat. 2016. PMID: 26957110 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year